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used for an adult sample aged >20 years, the prevalence of obesity among U.S. adults overall was 32.2% during 2003-2004 (3) , approximately one third greater than the 23.9% prevalence reported in the 2005 BRFSS survey. Second, persons who use only cellular telephones or are without land-line telephones are not included in BRFSS surveys. Persons with no telephone might be of lower socioeconomic status (9) , a factor associated with obesity (10) ; exclusion of these persons might result in underreporting of obesity prevalence.
Multiple CDC programs address prevention of obesity through nutrition and physical activity. Specifically, CDC's Nutrition and Physical Activity Program to Prevent Obesity and Other Chronic Diseases works collaboratively with state health departments to implement and evaluate interventions to increase physical activity and improve nutrition. The Steps to a HealthierUS program established by the U.S. Department of Health and Human Services in 2003 and overseen by CDC provides funding to 40 communities nationwide to use evidence-based strategies to prevent and reduce the burden of obesity. CDC's Coordinated School Health Program works through state education and health agencies to improve nutrition and increase physical activity in schools.
The continued increase in obesity prevalence underscores the need for additional measures to educate and motivate persons to make healthier choices and to establish social and physical environments that support those choices. To reduce obesity in the United States, an effective public health response will require a robust combination of policies, programs, and supportive environments created through the combined activities of health-care agencies, government, media, business and industry, communities, schools, families, and individuals. In addition, monitoring and evaluation systems are needed to ensure effectiveness of both new and existing interventions and to validate their widening use. To collect vaccination data for age-eligible children, NIS uses a quarterly random-digit-dialed sample of telephone numbers for each survey area. NIS methodology, including the weighting of responses to represent the entire population of children aged 19-35 months, has been described previously (1) (Figure) . In the 2005 NIS survey cohort, coverage levels for the 4:3:1:3:3:1 series were similar among racial/ethnic groups, which represents an improvement over recent years; an evaluation of NIS data from 1996 to 2002 revealed increasing or stable racial/ethnic disparities in the 4:3:1:3:3 vaccination series coverage levels for black and Hispanic children compared with white children (8) . Continued monitoring is needed to determine whether the narrowing gaps in coverage among racial/ethnic groups persist. Monitoring the disparities in administration of DTP/DT/DTaP, varicella vaccine, and PCV will be important, particularly for PCV, which protects against a disease with higher incidence among black children.
The only statistically significant decrease in coverage from 2004 to 2005 was for >1 dose of MMR. However, this decrease was modest, and national MMR coverage has remained consistent, ranging from 91% to 93% since 2001. The recent outbreak of mumps in the United States underscores the importance of timely administration of the first dose of MMR and the need for administration of the second dose at ages 4-6 years. Coverage in this age group is assessed by state health departments in their evaluation of school entry immunization requirements (9) .
The findings in this report are subject to at least three limitations. First, NIS is a telephone survey; although NIS results are weighted to make them representative of all children aged 19-35 months (e.g., accounting for nonresponse and households without telephones), some bias might remain after these statistical adjustments. Second, NIS uses provider-verified vaccination histories and assumes that coverage among children whose providers did not respond is similar to coverage among children whose providers did respond; thus, incomplete reporting might have resulted in underestimates of coverage. Finally, although national estimates are precise (1), annual estimates and trends for states and urban areas should be interpreted with caution because of wider confidence intervals.
High vaccination coverage levels should be achieved and maintained to reduce the impact of vaccine-preventable diseases. Routine childhood vaccination with the vaccines included in the 4:3:1:3:3:1 series results in net societal savings of an estimated $43 billion per annual birth cohort (10) . Coverage varied substantially by state, ranging from 63% to 91% for the 4:3:1:3:3:1 vaccine series, and by race/ethnicity for DT/DTP/DTaP, varicella vaccine, and PCV, indicating that further progress in increasing coverage is needed in many areas. NIS data will continue to be used to monitor vaccination status among preschool-aged children for recommended vaccines. Future NIS data will be used to assess routine rotavirus and hepatitis A vaccination of preschool-aged children, recommended in 2006, and use of a measles-mumpsrubella-varicella (MMRV) vaccine licensed in 2005.
In addition to the recently recommended vaccines for preschool-aged children, three vaccines have been recommended recently for children aged 11-12 years: meningococcal conjugate vaccine (MCV4); tetanus, diphtheria, and acellular pertussis (Tdap) vaccine instead of tetanus and diphtheria toxoids vaccine (Td); and human papillomavirus vaccine (HPV). The NIS will be expanded during the fourth quarter of 2006 to assess coverage for recommended vaccines received among children aged 13-17 years. This enhancement underscores the importance of survey systems such as the NIS in monitoring new vaccine implementation, which can provide valuable information for improving overall vaccination coverage.
Public Health Response to Varicella OutbreaksUnited States, 2003-2004
Since introduction of varicella vaccine in 1995, incidence of varicella has decreased as vaccination coverage has increased (1,2). Nevertheless, varicella outbreaks continue to occur, even among populations with high vaccination coverage (3) (4) (5) . Although varicella typically is mild, the outbreaks can last for several months and be challenging and costly for health departments to control. In 2005, CDC conducted a national survey to determine the distribution and extent of reported varicella outbreaks during 2003-2004 and the public health response. This report summarizes the results of that survey, which indicated that varicella outbreaks are still common and that health jurisdictions are responding to these outbreaks, although they have varying definitions and guidelines for varicella-outbreak management. Fifty-five (93%) of 59 jurisdictions responded to the survey; Alaska, New Mexico, Utah, and the U.S. Virgin Islands did not participate. In 2003, 43 (78%) of the 55 jurisdictions were notified of at least one varicella outbreak, and 10 (18%) were notified of six or more; in 2004, 45 (82%) were notified of at least one varicella outbreak, and 13 (24%) were notified of six or more. Additional information regarding 190 outbreaks that occurred in 2004 was obtained from 24 jurisdictions. Of the outbreaks reported to these jurisdictions, 67% occurred in elementary schools, and 43% included patients with a median age of 5-9 years; 64% had <10 cases, 26% had 11-40 cases, and 10% had 41-50 cases.
When asked whether their health jurisdiction had a formal program definition for varicella outbreaks, approximately 70% of the 55 responding jurisdictions indicated that they did, and the definitions varied ( Figure 1 ). Forty-four percent of jurisdictions reported that they had guidelines for managing varicella outbreaks. When asked whether their health jurisdiction responds to an outbreak if notified, † 47 of the 55 jurisdictions reported that they did. Thirty (55%) of these jurisdictions stated that their outbreak response involved both local and state health departments, 10 (18%) said that it involved the state health department only, and seven (13%) said that it involved the local health department only; eight jurisdictions did not respond. Among the 47 jurisdictions that respond to outbreaks, the most commonly reported criteria used to determine whether to respond were the population affected (57%), the outbreak setting (68%), and the size of the outbreak (68%); the age of patients was a less frequently used criterion (40%) (Figure 2 ). Approximately 35% of jurisdictions identified at least one other criterion.
* Health jurisdictions that receive federal grants to assist with vaccination programs. † Jurisdictions were asked, "Does your health department at times respond to varicella outbreaks? (Note: By 'respond,' at minimum, recording reported outbreaks in a log book including total number of cases, with or without additional variables.)" Possible replies were "Yes, state and local health departments respond; yes, only state health department responds; yes, only local health department responds; or no, there is no response."
Among the jurisdictions that respond to outbreaks, frequently used response strategies included verifying vaccination history, excluding patients from the outbreak setting, and documenting relevant outbreak information, such as age of patients. Vaccinating or excluding susceptible contacts from the outbreak setting and conducting laboratory testing to assess susceptibility were not frequently used strategies (Table) . Approximately two thirds of jurisdictions have formal, but varying, definitions for a varicella outbreak, and almost half of jurisdictions have existing varicella-outbreak management guidelines. Creating a standard definition for varicella outbreaks would be useful for monitoring the outbreak trends among jurisdictions, and establishing outbreak management guidelines might facilitate a more uniform response, especially at the local level, and ensure that critical procedures are not overlooked. CDC is working with state and local health departments to develop a standard definition and national guidelines for management of varicella outbreaks to be published in a future MMWR.
Forty-seven of the jurisdictions indicate that they respond to varicella outbreaks if notified, although response strategies vary. A standard response for all varicella outbreaks should include a letter from the local health department or outbreak setting to inform the affected population of the outbreak. In addition, persons without evidence of immunity § (6) should be vaccinated either by their primary-care physician or at a vaccination clinic in outbreak settings. Vaccination of susceptible populations who might have been exposed during an outbreak or who have been exposed to infection is important to prevent illness and decrease disease severity.
In June 2005, the Advisory Committee on Immunization Practices (ACIP) provisionally recommended a second dose of varicella vaccine in outbreak settings for persons who have had only 1 dose of varicella vaccine and no disease history (provided that an appropriate interval has elapsed since the first dose) (6) . On the basis of a 10-year follow-up prelicensure study of the vaccine, a 2-dose vaccination regimen has been determined more effective than a 1-dose regimen (7).
In a 2006 position statement, the Council of State and Territorial Epidemiologists (CSTE) supported a routine 2-dose (8) . Case-based reporting should improve detection of varicella outbreaks, the quality of the data reported from outbreaks, and the evaluation of outbreak-control measures.
The findings in this report are subject to at least two limitations. First, the data are taken from reports from jurisdictions and are subject to reporting biases such as recall bias. Second, varying outbreak definitions and reporting methods might have led to underestimation of the extent and distribution of varicella outbreaks.
As national outbreak guidelines are being created, jurisdictions are encouraged to contact CDC for assistance with investigating and responding to varicella outbreaks. Guidance on outbreak management and investigation also can be found in CDC's Manual for the Surveillance of Vaccine-Preventable Diseases (9) . Table) . A total of 921 (57%) cases for which such data were available occurred in males; median age of patients was 51 years (range: 3 months-95 years). Dates of illness onset ranged from January 6 to September 10; a total of 52 cases were fatal.
A Additional information about national WNV activity is available from CDC at http://www.cdc.gov/ncidod/dvbid/ westnile/index.htm and at http://westnilemaps.usgs.gov.
Notice to Readers

Epidemiology in Action CourseOctober 23-November 3, 2006
The Rollins School of Public Health's Hubert Department of Global Health and CDC's Office of Workforce and Career Development will cosponsor a course, Epidemiology in Action, October 23-November 3, 2006, at the Emory University campus in Atlanta, Georgia. The course is designed for state and local public health workers.
The course emphasizes the practical application of epidemiology to public health problems and will consist of lectures, workshops, classroom exercises (including actual epidemiologic problems), and roundtable discussions. Topics include descriptive epidemiology and biostatistics, analytic epidemiology, epidemic investigations, public health surveillance, surveys and sampling, Epi Info (Windows version) training, and discussions of selected prevalent diseases. Tuition is charged.
Additional information and applications are available from Emory University, Hubert Department of Global Health (attention: Pia), 1518 Clifton Road NE, Room 746, Atlanta, GA 30322; by telephone, 404-727-3485; fax, 404-727-4590; online at http://www.sph.emory.edu/epicourses; or by e-mail, pvaleri@sph.emory.edu.
Notice to Readers
Preventive Medicine Residency Application Deadline -October 11, 2006
The Preventive Medicine Residency (PMR) is accepting applications from physicians with public health and applied epidemiologic practice experience who seek to become preventive medicine/population health specialists and public health leaders. The PMR prepares physicians for leadership roles in public health at federal, state, and local levels through instruction and supervised practical experiences focused on translating epidemiology to public health practice, management, and policy and program development. Residents spend the practicum year at CDC or in a state or local health department.
PMR alumni occupy many leadership positions at CDC, at state and local health departments, and in academia and private-sector agencies. Completion of the PMR, which is accredited by the Accreditation Council for Graduate Medical Education for 12 months of practicum training, qualifies graduates to apply for certification by the American Board of Preventive Medicine in Public Health and General Preventive Medicine.
Applications are being accepted for the class that begins in mid-June 2007. Application materials must be postmarked by October 11, 2006. Additional information regarding the residency, eligibility criteria, and application process is available at http://www.cdc.gov/epo/dapht/pmr/pmr.htm or by telephone, 404-498-6140.
Errata: Vol. 55, No. RR-11
In the MMWR Recommendations and Reports, "Sexually Transmitted Diseases Treatment Guidelines, 2006," the following errors occurred:
On page 42, in the section "Chlamydial Infections Among Children" under "Diagnostic Considerations," the second recommended regimen should read: Recommended Regimen for Children Who Weigh >45 kg but Who Are Aged <8 Years.
On page 48, in the section "Gonococcal Infections Among Children" under "Diagnostic Considerations," the first recommended regimen should read: Recommended Regimens for Children Who Weigh >45 kg.
On page 59, under "Recommended Regimen A," the daily dosage for Ofloxacin was incorrect. It should read: Ofloxacin 400 mg orally twice daily for 14 days*. According to 2002 survey data, among non-Hispanic whites, the birth of the first child occurred during marriage for 77% of males and 74% of females. Among Hispanics, the birth of the first child occurred during marriage for 52% of males and 54% of females, and, among non-Hispanic blacks, it occurred during marriage for 37% of males and 23% of females. † Calculated by summing the incidence counts for the current week, the two weeks preceding the current week, and the two weeks following the current week, for a total of 5 preceding years. Additional information is available at http://www.cdc.gov/epo/dphsi/phs/files/5yearweeklyaverage.pdf. § Not notifiable in all states. ¶ Includes both neuroinvasive and non-neuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, VectorBorne, and Enteric Diseases (proposed) (ArboNET Surveillance). ** Data for H. influenzae (all ages, all serotypes) are available in Table II . † † Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed)). Implementation of HIV reporting influences the number of cases reported. Data for HIV/AIDS are available in Table IV . *** Of the two measles cases were reported for the current week, one was indigenous and one was imported from another country. † † † Data for meningococcal disease (all serogroups and unknown serogroups) are available in Table II. A n t h r a x  -1  0  ---2  2 3  Botulism:  foodborne  -3  1  19  16  20  28  39  infant  -81  2  90  87  76  69 American Samoa Massachusetts  1  0  2  15  27  1  0  2  15  5  2  22  43  594  702  New Hampshire  -0  2  5  10  -0  2  5  10  1  2  36  122  45  Rhode Island  -0  1  -2  -0  0  ---0  17  -21  Vermont†   -0  1  2  5  -0  0  -2  1  1  14 -0  2  7  15  -0  2  7  15  3  2  5  52  117  Mississippi  -0  1  2  5  -0  1  2  5  -0  4  23  45  Tennessee†   -0  2  15  20  -0  2  10  11  2  2  10 109 176 -1  23  48  89  -0  6  20  23  -19  360  446  1,640  Arkansas  -0  3  9  11  -0  2  6  3  -2  21  41  231  Louisiana  -0  1  3  28  -0  1  1  5  -0  3  5  43  Oklahoma  -0  4  8  13  -0  0  -2  -0  124  18  1  Texas†   -1  16  28  37  -0  4  13  13  -18  215  382  1,365   Mountain  -1  5  49  73  -0  4  25  21  30  63  230  1,945  2,933  Arizona  -0  3  15  30  -0  3  15  10  2  11  177  388  740  Colorado  -0  2  15  15  -0  1  3  -7  21  40  580  931  Idaho†   -0  2  3  4  -0  2  2  3  1  2  11  60  156  Montana  -0  1  3  --0  1  1  -3  2  11  90  527  Nevada†   -0  2 1  5  29  238  189  1  5  25  203  183  -45  1,334  1,314  2,448  Alaska  -0  1  2  1  -0  1  2  1  -2  15  51  79  California  1  3  14  146  124  1  3  14  146  124  -28  1,136  889  1,051  H a w a i i  -0  1  6  1 0  -0  1  6  5  -1  6  5 2  1 3 0  Oregon†   -1  7  57  35  -1  4  38  35  -2  9  88  583  Washington  -0  25  27  19  -0  11  11  18  -7  195  234 
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